Invitae's Q4 Revenues Increase More Than Threefold | GenomeWeb

This article has been updated to include additional information from Invitae's earnings call held Tuesday.

NEW YORK (GenomeWeb) – Invitae reported on Tuesday after the close of the market that its fourth quarter revenues increased more than three-fold year-over-year.

The San Francisco-based genetic testing firm recorded $3.2 million in revenues for the three months ended Dec. 31, 2015, compared to $875,000 in the fourth quarter of 2014 and beat analysts' consensus estimate of $2.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.